Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Consumer products brands are shifting from competing for visibility to competing for algorithmic selection, according to an EY report.
MedLife Group has implemented an advanced integrated robotic neurosurgery system at MedLife Polisano Hospital in Sibiu, following an investment of over €2 million.
The Galați Court has approved the modified asset recovery plan for Liberty Galați, paving the way for the auction of one of Romania's most important industrial assets to resume.
Romania has risen in Europe's investment destination rankings, becoming one of the most attractive markets in the region alongside Poland for international investors, according to PwC Global CEO Survey 2026 data.
Small and mid-sized retailers lost approximately €3.2 million in profit over the past year due to inventory errors, according to internal data from Selectsoft, a Romanian provider of ERP solutions for SMEs.